Idiopathic rapid eye movement sleep behavior disorder (iRBD) is a condition that often evolves into Parkinson's disease (PD). Therefore, by monitoring iRBD it is possible to track the neurodegeneration of individuals who may progress to PD. Here we aimed at piloting the characterization of brain tissue properties in mid-brain subcortical regions of 10 healthy subjects, 8 iRBD, and 9 early-diagnosed PD. We used a battery of magnetic resonance imaging (MRI) contrasts at 3 T, including adiabatic and non-adiabatic rotating frame techniques developed by our group, along with diffusion tensor imaging (DTI) and resting-state fMRI. Adiabatic T1ρ and T2ρ, and non-adiabatic RAFF4 (Relaxation Along a Fictitious Field in the rotating frame of rank 4) were found to have lower coefficient of variations and higher sensitivity to detect group differences as compared to DTI parameters such as fractional anisotropy and mean diffusivity. Significantly longer T1ρ were observed in the amygdala of PD subjects vs. controls, along with a trend of lower functional connectivity as measured by regional homogeneity, thereby supporting the notion that amygdalar dysfunction occurs in PD. Significant abnormalities in reward networks occurred in iRBD subjects, who manifested lower network strength of the accumbens. In agreement with previous studies, significantly longer T1ρ occurred in the substantia nigra compacta of PD vs. controls, indicative of neuronal degeneration, while regional homogeneity was lower in the substantia nigra reticulata. Finally, other trend-level findings were observed, i.e., lower RAFF4 and T2ρ in the midbrain of iRBD subjects vs. controls, possibly indicating changes in non-motor features as opposed to motor function in the iRBD group. We conclude that rotating frame relaxation methods along with functional connectivity measures are valuable to characterize iRBD and PD subjects, and with proper validation in larger cohorts may provide pathological signatures of iRBD and PD.

Central European Institute of Technology Masaryk University Brno Czechia

Department of Applied Physics University of Eastern Finland Kuopio Finland

Department of Neurology University of Minnesota Minneapolis MN United States

Department of Pediatrics University of Minnesota Minneapolis MN United States

Department of Radiology Center for Magnetic Resonance Research University of Minnesota Minneapolis MN United States

Division of Biostatistics University of Minnesota Minneapolis MN United States

Fondazione Santa Lucia IRCCS Rome Italy

MARBILab Centro Fermi Museo Storico Della Fisica e Centro di Studi e Ricerche Enrico Fermi Rome Italy

Erratum v

Front Neurosci. 2018 Jun 26;12:446. doi: 10.3389/fnins.2018.00446. PubMed

Zobrazit více v PubMed

Andersson J. L., Skare S., Ashburner J. (2003). How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. Neuroimage 20, 870–888. 10.1016/S1053-8119(03)00336-7 PubMed DOI

Andersson J. L., Sotiropoulos S. N. (2016). An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage 125, 1063–1078. 10.1016/j.neuroimage.2015.10.019 PubMed DOI PMC

Andronesi O. C., Bhat H., Reuter M., Mukherjee S., Caravan P., Rosen B. R. (2014). Whole brain mapping of water pools and molecular dynamics with rotating frame MR relaxation using gradient modulated low-power adiabatic pulses. Neuroimage 89, 92–109. 10.1016/j.neuroimage.2013.12.007 PubMed DOI PMC

Behzadi Y., Restom K., Liau J., Liu T. T. (2007). A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage 37, 90–101. 10.1016/j.neuroimage.2007.04.042 PubMed DOI PMC

Benjamini Y., Hochberg Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300.

Boeve B. F. (2013). Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease. Lancet Neurol. 12, 469–482. 10.1016/S1474-4422(13)70054-1 PubMed DOI PMC

Boeve B. F., Silber M. H., Ferman T. J., Lucas J. A., Parisi J. E. (2001). Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov. Disord. 16, 622–630. 10.1002/mds.1120 PubMed DOI

Bohnen N. I., Gedela S., Herath P., Constantine G. M., Moore R. Y. (2008). Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity. Neurosci. Lett. 447, 12–16. 10.1016/j.neulet.2008.09.070 PubMed DOI PMC

Bolding M. S., Reid M. A., Avsar K. B., Roberts R. C., Gamlin P. D., Gawne T. J., et al. . (2013). Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology. Biol. Psychiatry 73, 289–294. 10.1016/j.biopsych.2012.07.035 PubMed DOI PMC

Bouchard T. P., Malykhin N., Martin W. R., Hanstock C. C., Emery D. J., Fisher N. J., et al. . (2008). Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol. Aging 29, 1027–1039. 10.1016/j.neurobiolaging.2007.02.002 PubMed DOI

Bunzeck N., Singh-Curry V., Eckart C., Weiskopf N., Perry R. J., Bain P. G., et al. . (2013). Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease. Parkinsonism Relat. Disord. 19, 1136–1142. 10.1016/j.parkreldis.2013.08.011 PubMed DOI PMC

Bushnell D. M., Martin M. L. (1999). Quality of life and Parkinson's disease: translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39). Qual. Life Res. 8, 345–350. 10.1023/A:1008979705027 PubMed DOI

Casula V., Nissi M. J., Podlipska J., Haapea M., Koski J. M., Saarakkala S., et al. . (2017). Elevated adiabatic T1rho and T2rho in articular cartilage are associated with cartilage and bone lesions in early osteoarthritis: a preliminary study. J. Magn. Reson. Imaging 46, 678–689. 10.1002/jmri.25616 PubMed DOI

Cox R. W. (1996). AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput. Biomed. Res. 29, 162–173. 10.1006/cbmr.1996.0014 PubMed DOI

Dibble L. E., Cavanaugh J. T., Earhart G. M., Ellis T. D., Ford M. P., Foreman K. B. (2010). Charting the progression of disability in Parkinson disease: study protocol for a prospective longitudinal cohort study. BMC Neurol. 10:110. 10.1186/1471-2377-10-110 PubMed DOI PMC

Double K. L., Rowe D. B., Hayes M., Chan D. K., Blackie J., Corbett A., et al. . (2003). Identifying the pattern of olfactory deficits in parkinson disease using the brief smell identification test. Arch. Neurol. 60, 545–549. 10.1001/archneur.60.4.545 PubMed DOI

Du G., Lewis M. M., Styner M., Shaffer M. L., Sen S., Yang Q. X., et al. . (2011). Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov. Disord. 26, 1627–1632. 10.1002/mds.23643 PubMed DOI PMC

Ellmore T. M., Castriotta R. J., Hendley K. L., Aalbers B. M., Furr-Stimming E., Hood A. J., et al. . (2013). Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder. Sleep 36, 1885–1892. 10.5665/sleep.3222 PubMed DOI PMC

Fahn S., Elton R. (1987). Unified parkinson's disease rating scale, in Recent Developments in Parkinson's Disease, Vol. 2, eds Fahn S., Marsden C. D., Calne D. B., Goldstein M. (Florham Park, NJ: Macmillan Healthcare Information; ), 153–163.

Feldmann A., Illes Z., Kosztolanyi P., Illes E., Mike A., Kover F., et al. . (2008). Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov. Disord. 23, 42–46. 10.1002/mds.21765 PubMed DOI

Fischl B., Salat D. H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. . (2002). Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341–355. 10.1016/S0896-6273(02)00569-X PubMed DOI

Gagnon J. F., Postuma R. B., Joncas S., Desjardins C., Latreille V. (2010). The Montreal Cognitive Assessment: a screening tool for mild cognitive impairment in REM sleep behavior disorder. Mov. Disord. 25, 936–940. 10.1002/mds.23079 PubMed DOI

Goetz C. G., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stebbins G. T., et al. . (2007). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov. Disord. 22, 41–47. 10.1002/mds.21198 PubMed DOI

Goetz C. G., Tilley B. C., Shaftman S. R., Stebbins G. T., Fahn S., Martinez-Martin P., et al. . (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129–2170. 10.1002/mds.22340 PubMed DOI

Gorell J., Ordidge R., Brown G. (1995). Increased iron -related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 45, 1138–1143. 10.1212/WNL.45.6.1138 PubMed DOI

Greve D. N., Fischl B. (2009). Accurate and robust brain image alignment using boundary-based registration. Neuroimage 48, 63–72. 10.1016/j.neuroimage.2009.06.060 PubMed DOI PMC

Griffith C. J., Wijdicks C. A., Goerke U., Michaeli S., Ellermann J., LaPrade R. F. (2011). Outcomes of untreated posterolateral knee injuries: an in vivo canine model. Knee Surg. Sports Traumatol. Arthrosc. 19, 1192–1197. 10.1007/s00167-010-1358-z PubMed DOI

Hakkarainen H., Sierra A., Mangia S., Garwood M., Michaeli S., Grohn O., et al. . (2016). MRI relaxation in the presence of fictitious fields correlates with myelin content in normal rat brain. Magn. Reson. Med. 75, 161–168. 10.1002/mrm.25590 PubMed DOI PMC

Halliday G. M. (2009). Thalamic changes in Parkinson's disease. Parkinsonism Relat. Disord. 15(Suppl. 3), S152–S155. 10.1016/S1353-8020(09)70804-1 PubMed DOI

Hamilton M. (1959). The assessment of anxiety states by rating. Br. J. Med. Psychol. 32, 50–55. 10.1111/j.2044-8341.1959.tb00467.x PubMed DOI

Hamilton M. (1960). A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56–62. 10.1136/jnnp.23.1.56 PubMed DOI PMC

Hamilton M. (1980). Rating depressive patients. J. Clin. Psychiatry 41(12 Pt 2), 21–24. PubMed

Hanyu H., Inoue Y., Sakurai H., Kanetaka H., Nakamura M., Miyamoto T., et al. . (2012). Voxel-based magnetic resonance imaging study of structural brain changes in patients with idiopathic REM sleep behavior disorder. Parkinsonism Relat. Disord. 18, 136–139. 10.1016/j.parkreldis.2011.08.023 PubMed DOI

Hawkes C. H., Shephard B. C., Daniel S. E. (1997). Olfactory dysfunction in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 62, 436–446. 10.1136/jnnp.62.5.436 PubMed DOI PMC

Holm S. (1979). A simple sequentially rejective Bonferroni test procedure. Scand. J. Stat. 6, 65–70.

Hoops S., Nazem S., Siderowf A. D., Duda J. E., Xie S. X., Stern M. B., et al. . (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73, 1738–1745. 10.1212/WNL.0b013e3181c34b47 PubMed DOI PMC

Hughes A. J., Daniel S. E., Kilford L., Lees A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181–184. 10.1136/jnnp.55.3.181 PubMed DOI PMC

Ibarretxe-Bilbao N., Junque C., Marti M. J., Valldeoriola F., Vendrell P., Bargallo N., et al. . (2010). Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: a voxel-based diffusion tensor imaging study. Mov. Disord. 25, 1888–1894. 10.1002/mds.23208 PubMed DOI

Ibarretxe-Bilbao N., Tolosa E., Junque C., Marti M. J. (2009). MRI and cognitive impairment in Parkinson's disease. Mov. Disord. 24(Suppl. 2), S748–S753. 10.1002/mds.22670 PubMed DOI

Idiyatullin D., Corum C., Park J. Y., Garwood M. (2006). Fast and quiet MRI using a swept radiofrequency. J. Magn. Reson. 181, 342–349. 10.1016/j.jmr.2006.05.014 PubMed DOI

Jellinger K. A. (2015). Neuropathobiology of non-motor symptoms in Parkinson disease. J. Neural. Transm. 122, 1429–1440. 10.1007/s00702-015-1405-5 PubMed DOI

Jenkinson M., Bannister P., Brady M., Smith S. (2002). Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17, 825–841. 10.1006/nimg.2002.1132 PubMed DOI

Jenkinson M., Beckmann C. F., Behrens T. E., Woolrich M. W., Smith S. M. (2012). Fsl. Neuroimage 62, 782–790. 10.1016/j.neuroimage.2011.09.015 PubMed DOI

Jokivarsi K. T., Niskanen J. P., Michaeli S., Grohn H. I., Garwood M., Kauppinen R. A., et al. . (2009). Quantitative assessment of water pools by T 1 rho and T 2 rho MRI in acute cerebral ischemia of the rat. J. Cereb. Blood Flow Metab. 29, 206–216. 10.1038/jcbfm.2008.113 PubMed DOI PMC

Kamagata K., Motoi Y., Abe O., Shimoji K., Hori M., Nakanishi A., et al. . (2012). White matter alteration of the cingulum in Parkinson disease with and without dementia: evaluation by diffusion tensor tract-specific analysis. AJNR Am. J. Neuroradiol. 33, 890–895. 10.3174/ajnr.A2860 PubMed DOI PMC

Karagulle Kendi A. T., Lehericy S., Luciana M., Ugurbil K., Tuite P. (2008). Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am. J. Neuroradiol. 29, 501–505. 10.3174/ajnr.A0850 PubMed DOI PMC

Kaur D., Lee D., Ragapolan S., Andersen J. K. (2009). Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: implications for Parkinson's disease. Free Radic. Biol. Med. 46, 593–598. 10.1016/j.freeradbiomed.2008.11.012 PubMed DOI PMC

Kostic V. S., Agosta F., Petrovic I., Galantucci S., Spica V., Jecmenica-Lukic M., et al. . (2010). Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 75, 857–863. 10.1212/WNL.0b013e3181f11c1d PubMed DOI

Li S. X., Wing Y. K., Lam S. P., Zhang J., Yu M. W., Ho C. K., et al. . (2010). Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK). Sleep Med. 11, 43–48. 10.1016/j.sleep.2009.06.008 PubMed DOI

Liimatainen T., Hakkarainen H., Mangia S., Huttunen J. M., Storino C., Idiyatullin D., et al. . (2015). MRI contrasts in high rank rotating frames. Magn. Reson. Med. 73, 254–262. 10.1002/mrm.25129 PubMed DOI PMC

Liimatainen T., Mangia S., Ling W., Ellermann J., Sorce D. J., Garwood M., et al. . (2011). Relaxation dispersion in MRI induced by fictitious magnetic fields. J. Magn. Reson. 209, 269–276. 10.1016/j.jmr.2011.01.022 PubMed DOI PMC

Liimatainen T., Sierra A., Hanson T., Sorce D. J., Yla-Herttuala S., Garwood M., et al. . (2012). Glioma cell density in a rat gene therapy model gauged by water relaxation rate along a fictitious magnetic field. Magn. Reson. Med. 67, 269–277. 10.1002/mrm.22997 PubMed DOI PMC

Liimatainen T., Sorce D. J., O'Connell R., Garwood M., Michaeli S. (2010). MRI contrast from relaxation along a fictitious field (RAFF). Magn. Reson. Med. 64, 983–994. 10.1002/mrm.22372 PubMed DOI PMC

Luk K. C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J. Q., et al. . (2012). Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949–953. 10.1126/science.1227157 PubMed DOI PMC

Mangia S., Carpenter A. F., Tyan A. E., Eberly L. E., Garwood M., Michaeli S. (2013). Magnetization transfer and adiabatic T1rho MRI reveal abnormalities in normal-appearing white matter of subjects with multiple sclerosis. Mult. Scler. 20, 1066–1073. 10.1177/1352458513515084 PubMed DOI PMC

Mangia S., Liimatainen T., Garwood M., Michaeli S. (2009). Rotating frame relaxation during adiabatic pulses vs. conventional spin lock: simulations and experimental results at 4 T. Magn. Reson. Imaging 27, 1074–1087. 10.1016/j.mri.2009.05.023 PubMed DOI PMC

Martin W. R., Wieler M., Gee M. (2008). Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70(16 Pt 2), 1411–1417. 10.1212/01.wnl.0000286384.31050.b5 PubMed DOI

Maximo J. O., Keown C. L., Nair A., Muller R. A. (2013). Approaches to local connectivity in autism using resting state functional connectivity MRI. Front. Hum. Neurosci. 7:605. 10.3389/fnhum.2013.00605 PubMed DOI PMC

Menke R. A., Jbabdi S., Miller K. L., Matthews P. M., Zarei M. (2010). Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease. Neuroimage 52, 1175–1180. 10.1016/j.neuroimage.2010.05.086 PubMed DOI

Menke R. A., Scholz J., Miller K. L., Deoni S., Jbabdi S., Matthews P. M., et al. . (2009). MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 47, 435–441. 10.1016/j.neuroimage.2009.05.017 PubMed DOI

Michaeli S. (2007). Novel MRI contrasts measure in vivo characteristics of Parkinson's disease. Nat. Clin. Pract. Neurol. 3, 122–123. 10.1038/ncpneuro0411 DOI

Michaeli S., Grohn H., Grohn O., Sorce D. J., Kauppinen R., Springer C. S., et al. . (2005). Exchange-influenced T2rho contrast in human brain images measured with adiabatic radio frequency pulses. Magn. Reson. Med. 53, 823–829. 10.1002/mrm.20428 PubMed DOI

Michaeli S., Oz G., Sorce D. J., Garwood M., Ugurbil K., Majestic S., et al. . (2007). Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov. Disord. 22, 334–340. 10.1002/mds.21227 PubMed DOI

Michaeli S., Sorce D. J., Garwood M. (2008). T-2 rho and T-1 rho adiabatic relaxations and contrasts. Curr. Anal. Chem. 4, 8–25. 10.2174/157341108783339115 DOI

Michaeli S., Sorce D. J., Idiyatullin D., Ugurbil K., Garwood M. (2004). Transverse relaxation in the rotating frame induced by chemical exchange. J. Magn. Reson. 169, 293–239. 10.1016/j.jmr.2004.05.010 PubMed DOI

Michaeli S., Sorce D. J., Springer C. S., Jr., Ugurbil K., Garwood M. (2006). T1rho MRI contrast in the human brain: modulation of the longitudinal rotating frame relaxation shutter-speed during an adiabatic RF pulse. J. Magn. Reson. 181, 135–147. 10.1016/j.jmr.2006.04.002 PubMed DOI

Nasreddine Z. S., Phillips N. A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. . (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695–699. 10.1111/j.1532-5415.2005.53221.x PubMed DOI

Nestrasil I., Michaeli S., Liimatainen T., Rydeen C. E., Kotz C. M., Nixon J. P., et al. . (2010). T1rho and T2rho MRI in the evaluation of Parkinson's disease. J. Neurol. 257, 964–968. 10.1007/s00415-009-5446-2 PubMed DOI PMC

Ogisu K., Kudo K., Sasaki M., Sakushima K., Yabe I., Sasaki H., et al. . (2013). 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease. Neuroradiology 55, 719–724. 10.1007/s00234-013-1171-8 PubMed DOI

Okuaki T., Takayama Y., Nishie A., Ogino T., Obara M., Honda H., et al. . (2017). T1rho mapping improvement using stretched-type adiabatic locking pulses for assessment of human liver function at 3T. Magn. Reson. Imaging 40, 17–23. 10.1016/j.mri.2017.03.006 PubMed DOI

Peran P., Cherubini A., Assogna F., Piras F., Quattrocchi C., Peppe A., et al. . (2010). Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 133, 3423–3433. 10.1093/brain/awq212 PubMed DOI

Power J. D., Barnes K. A., Snyder A. Z., Schlaggar B. L., Petersen S. E. (2012). Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 59, 2142–2154. 10.1016/j.neuroimage.2011.10.018 PubMed DOI PMC

Prodoehl J., Li H., Planetta P. J., Goetz C. G., Shannon K. M., Tangonan R., et al. . (2013). Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor. Mov. Disord. 28, 1816–1822. 10.1002/mds.25491 PubMed DOI PMC

Rolheiser T. M., Fulton H. G., Good K. P., Fisk J. D., McKelvey J. R., Scherfler C., et al. . (2011). Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease. J. Neurol. 258, 1254–1260. 10.1007/s00415-011-5915-2 PubMed DOI

Satzer D., DiBartolomeo C., Ritchie M. M., Storino C., Liimatainen T., Hakkarainen H., et al. . (2015). Assessment of dysmyelination with RAFFn MRI: application to murine MPS I. PLoS ONE 10:e0116788. 10.1371/journal.pone.0116788 PubMed DOI PMC

Schenck C. H., Bundlie S. R., Ettinger M. G., Mahowald M. W. (1986). Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9, 293–308. 10.1093/sleep/9.2.293 PubMed DOI

Schenck C. H., Bundlie S. R., Mahowald M. W. (1996). Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46, 388–393. 10.1212/WNL.46.2.388 PubMed DOI

Scherfler C., Frauscher B., Schocke M., Iranzo A., Gschliesser V., Seppi K., et al. . (2011). White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann. Neurol. 69, 400–407. 10.1002/ana.22245 PubMed DOI

Sierra A., Michaeli S., Niskanen J. P., Valonen P. K., Grohn H. I., Yla-Herttuala S., et al. . (2008). Water spin dynamics during apoptotic cell death in glioma gene therapy probed by T1rho and T2rho. Magn. Reson. Med. 59, 1311–1319. 10.1002/mrm.21600 PubMed DOI PMC

Silveira-Moriyama L., Petrie A., Williams D. R., Evans A., Katzenschlager R., Barbosa E. R., et al. . (2009). The use of a color coded probability scale to interpret smell tests in suspected parkinsonism. Mov. Disord. 24, 1144–1153. 10.1002/mds.22494 PubMed DOI

Smith S. M. (2002). Fast robust automated brain extraction. Hum. Brain Mapp. 17, 143–155. 10.1002/hbm.10062 PubMed DOI PMC

Song S. K., Lee J. E., Park H. J., Sohn Y. H., Lee J. D., Lee P. H. (2011). The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov. Disord. 26, 289–296. 10.1002/mds.23477 PubMed DOI

Tuite P. J., Mangia S., Tyan A. E., Lee M. K., Garwood M., Michaeli S. (2012). Magnetization transfer and adiabatic R 1rho MRI in the brainstem of Parkinson's disease. Parkinsonism Relat. Disord. 18, 623–625. 10.1016/j.parkreldis.2012.01.003 PubMed DOI PMC

Vaillancourt D. E., Spraker M. B., Prodoehl J., Abraham I., Corcos D. M., Zhou X. J., et al. . (2009). High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72, 1378–1384. 10.1212/01.wnl.0000340982.01727.6e PubMed DOI PMC

van Mierlo T. J., Chung C., Foncke E. M., Berendse H. W., van den Heuvel O. A. (2015). Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume. Mov. Disord. 30, 245–252. 10.1002/mds.26112 PubMed DOI

Vriend C., Boedhoe P. S., Rutten S., Berendse H. W., van der Werf Y. D., van den Heuvel O. A. (2016). A smaller amygdala is associated with anxiety in Parkinson's disease: a combined FreeSurfer-VBM study. J. Neurol. Neurosurg. Psychiatry 87, 493–500. 10.1136/jnnp-2015-310383 PubMed DOI

Yushkevich P. A., Piven J., Hazlett H. C., Smith R. G., Ho S., Gee J. C., et al. . (2006). User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31, 1116–1128. 10.1016/j.neuroimage.2006.01.015 PubMed DOI

Zang Y., Jiang T., Lu Y., He Y., Tian L. (2004). Regional homogeneity approach to fMRI data analysis. Neuroimage 22, 394–400. 10.1016/j.neuroimage.2003.12.030 PubMed DOI

Zecca L., Casella L., Albertini A., Bellei C., Zucca F. A., Engelen M., et al. . (2008). Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. J. Neurochem. 106, 1866–1875. 10.1111/j.1471-4159.2008.05541.x PubMed DOI

Zhang J., Nissi M. J., Idiyatullin D., Michaeli S., Garwood M., Ellermann J. (2016). Capturing fast relaxing spins with SWIFT adiabatic rotating frame spin-lattice relaxation (T1ρ) mapping. NMR Biomed. 29, 420–430. 10.1002/nbm.3474 PubMed DOI PMC

Wide-spread brain alterations early after the onset of Crohn's disease in children in remission-a pilot study

Reducing thermal noise in high-resolution quantitative magnetic resonance imaging rotating frame relaxation mapping of the human brain at 3 T

Rotating frame MRI relaxations as markers of diffuse white matter abnormalities in multiple sclerosis